You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for TRI-MILI


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for TRI-MILI

Average Pharmacy Cost for TRI-MILI

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
TRI-MILI 28 TABLET 65862-0777-28 0.12315 EACH 2024-12-18
TRI-MILI 28 TABLET 65862-0777-85 0.12315 EACH 2024-12-18
TRI-MILI 28 TABLET 65862-0777-28 0.11796 EACH 2024-11-20
TRI-MILI 28 TABLET 65862-0777-85 0.11796 EACH 2024-11-20
TRI-MILI 28 TABLET 65862-0777-28 0.13732 EACH 2024-10-23
TRI-MILI 28 TABLET 65862-0777-85 0.13732 EACH 2024-10-23
TRI-MILI 28 TABLET 65862-0777-28 0.13455 EACH 2024-09-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

TRI-MILI Market Analysis and Financial Projection

Market Analysis and Price Projections for Tri-Mili

Introduction to Tri-Mili

Tri-Mili, a generic version of Ortho Tri-Cyclen®, is an estrogen/progestin combined oral contraceptive (COC) developed by Aurobindo Pharma. It is indicated for the prevention of pregnancy and the treatment of moderate acne vulgaris in females at least 15 years of age who have achieved menarche and have no known contraindications to oral contraceptive therapy[1][4].

Market Size and Demand

The market for oral contraceptives, including Tri-Mili, is substantial. As of 2018, the combined market size for products like Tri-Mili and its counterpart, Mili™, was estimated at $389.7 million for the twelve months ending February 2018, according to IQVIA data[1].

Pricing and Cost

The cost of Tri-Mili can vary depending on the pharmacy and the use of discount cards. As of recent data, the cost for a supply of 84 tablets of Tri-Mili (triphasic formulation) is around $41.87 for cash-paying customers. This price can be reduced significantly with the use of discount cards, such as the Drugs.com Discount Card, which can save up to 80% or more off the cost of prescription medicines[3].

Market Trends and Projections

Pharmaceutical Expenditure Growth

The overall pharmaceutical expenditure in the US has been on the rise. In 2022, it grew by 9.4% compared to 2021, reaching a total of $633.5 billion. This growth was driven by increased utilization, price changes, and the introduction of new drugs. For 2023, it is projected that overall prescription drug spending will rise by 6.0% to 8.0%, with clinics and hospitals experiencing increases of 8.0% to 10.0% and 1.0% to 3.0%, respectively[2].

Generic and Biosimilar Impact

The launch of generic drugs like Tri-Mili can significantly impact the market by offering more affordable alternatives to brand-name drugs. Generic versions often capture a substantial market share, leading to reduced prices and increased accessibility for consumers. However, the impact on overall spending can be complex, as it may also lead to increased utilization due to lower costs[2].

Competitive Landscape

Tri-Mili competes in a crowded market of oral contraceptives, including both brand-name and generic products. Aurobindo Pharma's extensive portfolio of oral contraceptive products, including 23 approvals, positions the company strongly in this market. The generic nature of Tri-Mili allows it to compete directly with brand-name products like Ortho Tri-Cyclen®, offering a cost-effective alternative[1].

Regulatory and Policy Impact

Changes in healthcare policies and regulations can significantly affect the pricing and accessibility of drugs like Tri-Mili. For instance, the Medicare Drug Price Negotiation Program, set to take effect in 2026, aims to reduce prescription drug costs for Medicare beneficiaries. While this program does not directly target oral contraceptives, it sets a precedent for future price negotiations and could influence the broader pharmaceutical market[5].

Patient Assistance and Discount Programs

To make Tri-Mili more accessible, various discount programs and patient assistance initiatives are available. The Drugs.com Discount Card, for example, can save patients up to 80% on the cost of Tri-Mili and other prescription medicines. These programs help in reducing the financial burden on patients and can increase the market penetration of the drug[3].

Side Effects and Safety Considerations

While Tri-Mili is generally safe and effective, it comes with certain warnings and precautions. These include the risk of serious cardiovascular events, venous thrombotic events, and liver disease. These safety considerations can impact patient adherence and may influence prescribing patterns, thereby affecting market demand[4].

Conclusion

Tri-Mili, as a generic oral contraceptive, operates within a dynamic market influenced by various factors including pharmaceutical expenditure trends, generic competition, regulatory policies, and patient assistance programs.

Key Takeaways

  • Market Size: The combined market size for Tri-Mili and similar products was estimated at $389.7 million as of 2018.
  • Pricing: The cost of Tri-Mili is around $41.87 for a supply of 84 tablets, with potential savings through discount cards.
  • Market Trends: Overall pharmaceutical expenditure is projected to rise, with generics and biosimilars playing a significant role.
  • Competitive Landscape: Tri-Mili competes with brand-name and other generic oral contraceptives.
  • Regulatory Impact: Future price negotiations and policy changes could influence the market.
  • Patient Assistance: Discount programs are available to make Tri-Mili more accessible.

FAQs

Q: What is Tri-Mili used for? A: Tri-Mili is used to prevent pregnancy and to treat moderate acne vulgaris in females at least 15 years of age who have achieved menarche and have no known contraindications to oral contraceptive therapy[1][4].

Q: How much does Tri-Mili cost? A: The cost of Tri-Mili is around $41.87 for a supply of 84 tablets, depending on the pharmacy and the use of discount cards[3].

Q: What are the potential side effects of Tri-Mili? A: Tri-Mili comes with warnings for serious cardiovascular events, venous thrombotic events, and liver disease. It also includes risks such as unscheduled bleeding and spotting[4].

Q: How does Tri-Mili compare to brand-name oral contraceptives? A: Tri-Mili is a generic equivalent to Ortho Tri-Cyclen®, offering a cost-effective alternative with similar efficacy and indications[1].

Q: Are there any discount programs available for Tri-Mili? A: Yes, discount programs like the Drugs.com Discount Card can save patients up to 80% on the cost of Tri-Mili and other prescription medicines[3].

Sources

  1. Aurobindo Pharma Launches Oral Contraceptives - BioSpace
  2. National trends in prescription drug expenditures and projections for ... - PubMed
  3. Tri-Mili Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com
  4. Tri-Lo-Mili: Package Insert / Prescribing Information - Drugs.com
  5. Medicare Drug Price Negotiation Program - CMS

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.